ChemBriefIndia's Gland Pharma beats quarterly profit view on strong Europe, US sales
India's Gland Pharma beat quarterly profit estimates with a $33.3 million net profit, driven by 32% U.S. and 20% European sales growth. Recovery at its Cenexi production units in France and Belgium su
reuters · 2026-08-10 04:08